KLK3 and posterior cortical atrophy: Another study predicted the clinical parameters and molecular biomarkers after PCa neoadjuvant chemohormonal therapy to evaluate the pathological response to neoadjuvant therapy; they found a lower preoperative PSA level was an independent predictor of good pathological response (Fan et al., 2023).